A versatile nanovaccine platform is based on a synthetic nanoparticle that not only acts as an antigen carrier but also stimulates the STING pathway.
References
Luo, M. et al. Nat. Nanotech. 12, 648–654 (2017).
Siddiqui, M. et al. BioDrugs 5, 313–316 (2006).
Cubillos-Ruiz, J. R. et al. J. Clin. Invest. 119, 2231–2244 (2009).
Lizotte, P. H. et al. Nat. Nanotech. 11, 295–303 (2016).
Ishikawa, H. et al. Nature 455, 674–678 (2008).
Corrales, L. et al. J. Clin. Invest. 126, 2404–2411 (2016).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fiering, S. Making allies of phagocytes. Nature Nanotech 12, 615–616 (2017). https://doi.org/10.1038/nnano.2017.89
Published:
Issue Date:
DOI: https://doi.org/10.1038/nnano.2017.89
- Springer Nature Limited
This article is cited by
-
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Cancer Immunology, Immunotherapy (2024)